123 related articles for article (PubMed ID: 15696966)
61. Detection of complex genetic alterations in human glioblastoma multiforme using comparative genomic hybridization.
Schlegel J; Scherthan H; Arens N; Stumm G; Kiessling M
J Neuropathol Exp Neurol; 1996 Jan; 55(1):81-7. PubMed ID: 8558174
[TBL] [Abstract][Full Text] [Related]
62. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.
Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H
Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932
[TBL] [Abstract][Full Text] [Related]
63. Incidence of the main genetic markers in glioblastoma multiforme is independent of tumor topology.
Necesalová E; Vranová V; Kuglík P; Cejpek P; Jarosová M; Pesáková M; Relichová J; Veselská R
Neoplasma; 2007; 54(3):212-8. PubMed ID: 17447852
[TBL] [Abstract][Full Text] [Related]
64. Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomic hybridization.
Weber RG; Sommer C; Albert FK; Kiessling M; Cremer T
Lab Invest; 1996 Jan; 74(1):108-19. PubMed ID: 8569172
[TBL] [Abstract][Full Text] [Related]
65. Systemic metastasis in glioblastoma may represent the emergence of neoplastic subclones.
Park CC; Hartmann C; Folkerth R; Loeffler JS; Wen PY; Fine HA; Black PM; Shafman T; Louis DN
J Neuropathol Exp Neurol; 2000 Dec; 59(12):1044-50. PubMed ID: 11138924
[TBL] [Abstract][Full Text] [Related]
66. Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene.
Ichimura K; Schmidt EE; Goike HM; Collins VP
Oncogene; 1996 Sep; 13(5):1065-72. PubMed ID: 8806696
[TBL] [Abstract][Full Text] [Related]
67. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.
Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H
J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672
[TBL] [Abstract][Full Text] [Related]
68. Homozygous deletions of cadherin genes in chondrosarcoma-an array comparative genomic hybridization study.
Niini T; Scheinin I; Lahti L; Savola S; Mertens F; Hollmén J; Böhling T; Kivioja A; Nord KH; Knuutila S
Cancer Genet; 2012 Nov; 205(11):588-93. PubMed ID: 23146407
[TBL] [Abstract][Full Text] [Related]
69. Amplification of the anonymous marker D17S67 in malignant astrocytomas.
Bijlsma EK; Leenstra S; Westerveld A; Bosch DA; Hulsebos TJ
Genes Chromosomes Cancer; 1994 Feb; 9(2):148-52. PubMed ID: 7513547
[TBL] [Abstract][Full Text] [Related]
70. Pediatric glioblastomas: a histopathological and molecular genetic study.
Suri V; Das P; Pathak P; Jain A; Sharma MC; Borkar SA; Suri A; Gupta D; Sarkar C
Neuro Oncol; 2009 Jun; 11(3):274-80. PubMed ID: 18981259
[TBL] [Abstract][Full Text] [Related]
71. PIK3CA mutations in glioblastoma multiforme.
Hartmann C; Bartels G; Gehlhaar C; Holtkamp N; von Deimling A
Acta Neuropathol; 2005 Jun; 109(6):639-42. PubMed ID: 15924253
[TBL] [Abstract][Full Text] [Related]
72. Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization.
Roman E; Meza-Zepeda LA; Kresse SH; Myklebost O; Vasstrand EN; Ibrahim SO
Oncol Rep; 2008 Oct; 20(4):825-43. PubMed ID: 18813824
[TBL] [Abstract][Full Text] [Related]
73. Loss of heterozygosity on chromosome 19 in secondary glioblastomas.
Nakamura M; Yang F; Fujisawa H; Yonekawa Y; Kleihues P; Ohgaki H
J Neuropathol Exp Neurol; 2000 Jun; 59(6):539-43. PubMed ID: 10850866
[TBL] [Abstract][Full Text] [Related]
74. Clinical and Molecular Characterization of Adult Glioblastomas in Southern Brazil.
Trevisan P; Graziadio C; Rodrigues DBK; Rosa RFM; Soares FP; Provenzi VO; de Oliveira CAV; Paskulin GA; Varella-Garcia M; Zen PRG
J Neuropathol Exp Neurol; 2019 Apr; 78(4):297-304. PubMed ID: 30840759
[TBL] [Abstract][Full Text] [Related]
75. Observations of the genomic landscape beyond 1p19q deletions and EGFR amplification in glioma.
Paxton CN; Rowe LR; South ST
Mol Cytogenet; 2015; 8():60. PubMed ID: 26257825
[TBL] [Abstract][Full Text] [Related]
76. Inhibition of epigenetic and cell cycle-related targets in glioblastoma cell lines reveals that onametostat reduces proliferation and viability in both normoxic and hypoxic conditions.
Lavogina D; Krõlov MK; Vellama H; Modhukur V; Di Nisio V; Lust H; Eskla KL; Salumets A; Jaal J
Sci Rep; 2024 Feb; 14(1):4303. PubMed ID: 38383756
[TBL] [Abstract][Full Text] [Related]
77. MTAP loss: a possible therapeutic approach for glioblastoma.
Patro CPK; Biswas N; Pingle SC; Lin F; Anekoji M; Jones LD; Kesari S; Wang F; Ashili S
J Transl Med; 2022 Dec; 20(1):620. PubMed ID: 36572880
[TBL] [Abstract][Full Text] [Related]
78. 2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology.
Epstein RJ; Tian LJ; Gu YF
J Oncol; 2021; 2021():9955456. PubMed ID: 34007277
[TBL] [Abstract][Full Text] [Related]
79. Intellectual disability: dendritic anomalies and emerging genetic perspectives.
Quach TT; Stratton HJ; Khanna R; Kolattukudy PE; Honnorat J; Meyer K; Duchemin AM
Acta Neuropathol; 2021 Feb; 141(2):139-158. PubMed ID: 33226471
[TBL] [Abstract][Full Text] [Related]
80. Loss of 5'-Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, it is Not Associated with Higher Tumor Aggressiveness.
Menezes WP; Silva VAO; Gomes INF; Rosa MN; Spina MLC; Carloni AC; Alves ALV; Melendez M; Almeida GC; Silva LSD; Clara C; da Cunha IW; Hajj GNM; Jones C; Bidinotto LT; Reis RM
Cells; 2020 Feb; 9(2):. PubMed ID: 32093414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
